Northwire Canada EditionFriday, July 17, 2026
Sign inSubscribe
Northwire
⌕
ZNX 0.080 +0.0% TSK 1.05 +0.5% SFR 0.370 +68.2% OMM 0.050 +0.0% EMO 0.330 −4.3% GGA 5.23 −1.3% MDM 0.060 +0.0% WGX 4.30 −2.9% FL 0.410 +0.0% SSRM 35.75 −1.7% CD 0.245 +6.5% GEN 0.065 −7.1% ALS 55.30 −3.8% LIFT 3.35 +6.3% NTR 94.10 −0.2% ICON 0.045 +0.0% ZNX 0.080 +0.0% TSK 1.05 +0.5% SFR 0.370 +68.2% OMM 0.050 +0.0% EMO 0.330 −4.3% GGA 5.23 −1.3% MDM 0.060 +0.0% WGX 4.30 −2.9% FL 0.410 +0.0% SSRM 35.75 −1.7% CD 0.245 +6.5% GEN 0.065 −7.1% ALS 55.30 −3.8% LIFT 3.35 +6.3% NTR 94.10 −0.2% ICON 0.045 +0.0%
Earnings

Extendicare Announces 2025 Third Quarter Results

By The Northwire Desk — AI Analysis Nov 11, 2025 · 17:00 EXE · 15.94 EXTENDICARE INC.
EXE · Price

Executive Summary

  • Extendicare reported strong Q3 2025 results, with Adjusted EBITDA up 36.6% YoY to $46.9 M and net earnings rising 48% to $24.1 M.
  • Completed the cash acquisition of Closing the Gap for $75.1 M (funded partly by a $55 M draw on its senior secured credit facility) plus an earn‑out potential of $1.5–$2.0 M.
  • Revenue grew 22.1% YoY to $440.3 M, driven by the Closing the Gap acquisition, nine Class C LTC home acquisitions and strong home‑health volume growth (ADV up 24.6%).

Key Details

  • Acquisition – Closing the Gap
  • Purchase price: $75.1 M cash (subject to working‑capital adjustments).
  • Funding: cash on hand + $55.0 M draw on senior secured credit facility.
  • Earn‑out: additional $1.5–$2.0 M payable at one‑year anniversary, tied to $3.0–$4.0 M of new‑business revenue.

  • Expected cost synergies: ~$1.1 M annualized in year 1.

  • Financial Highlights – Q3 2025 (vs. Q3 2024)

  • Revenue: $440.3 M (+22.1%); adjusted for out‑of‑period LTC funding, $436.4 M (+22.1%).
  • NOI(1): $65.9 M (+31.8%); excluding out‑of‑period items, $62.0 M (+28.3%).
  • Adjusted EBITDA(1): $50.8 M (+36.6%); excl. out‑of‑period, $46.9 M (+36.6%).
  • Net earnings: $24.1 M (+48%).

  • AFFO(1): $29.5 M ($0.349 per basic share); excl. out‑of‑period, $26.2 M ($0.309).

  • Financial Highlights – Nine Months Ended Sep 30 2025 (vs. 2024)

  • Revenue: $1,198.4 M (+13.2% adjusted).
  • NOI(1): $171.1 M (+21.3%).
  • Adjusted EBITDA(1): $126.2 M (+28.9%).
  • Net earnings: $71.1 M (+28.6%).

  • AFFO(1): $74.1 M ($0.877 per basic share).

  • Segment Performance

  • Long‑Term Care: Revenue $237.9 M (+17.9%); NOI $31.6 M; occupancy 98.5% (up 10 bps).
  • Home Health Care: ADV 37,609 (↑24.6% YoY); revenue $186.8 M (+35%); NOI $25.4 M (+63%).

  • Managed Services: Revenue $15.6 M (‑17.4%); NOI $8.9 M; beds served 152,100 (↑6%).

  • Liquidity – Cash & cash equivalents: $165.7 M; undrawn revolving credit facility capacity: $154.0 M.

  • Dividend – Board declared a cash dividend of $0.042 per share for November 2025 (payable Dec 15, 2025).

  • Conference Call – Scheduled for Nov 12 2025, 11:30 a.m. EDT; webcast available on company website.

Notable Quotes

“This quarter marks our strongest performance in recent years, reflecting margin improvements across all segments, augmented by a full quarter impact of our recent acquisitions,” — Dr. Michael Guerriere, President & CEO.

Materiality Assessment: Material – Positive (significant earnings growth and material acquisition).

Read the original news release →

More from EXTENDICARE INC.

Jun 05, 2026 · 16:15

Extendicare Joins TSX Composite as Home Health Merger Drives Scale and Investment-Grade Upgrade

Other May 12, 2026 · 10:06

Extendicare Confirms CBI Integration Success with Pro Forma Financials; Debt Restructuring Solidifies Investment Grade Status

Earnings May 07, 2026 · 17:24

Extendicare’s Investment-Grade Debut and CBI Close Cement a Transformative Growth Trajectory

Earnings Apr 14, 2026 · 08:39

Extendicare Closes Investment Grade Debt, Consolidating Growth Strategy

Financings Apr 09, 2026 · 17:55

Extendicare Secures Investment Grade Status, Refinances Debt to Fuel Senior Care Expansion

Financings Apr 01, 2026 · 21:05

Extendicare closes $570M CHI Home Health acquisition

M&A / Property